These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7872178)

  • 1. Prediction of electrophysiologic study results in patients treated with amiodarone.
    Ferrick KJ; Singh S; Roth JA; Kim SG; Fisher JD
    Am Heart J; 1995 Mar; 129(3):496-501. PubMed ID: 7872178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone therapy: role of early and late electrophysiologic studies.
    Greenspon AJ; Volosin KJ; Greenberg RM; Jefferies L; Rotmensch HH
    J Am Coll Cardiol; 1988 Jan; 11(1):117-23. PubMed ID: 3335688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
    J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective, randomized comparison of conventional and high dose loading regimens of amiodarone in the treatment of ventricular tachycardia.
    Kalbfleisch SJ; Williamson B; Man KC; Vorperian V; Hummel JD; Hasse C; Strickberger SA; Calkins H; Langberg JJ; Morady F
    J Am Coll Cardiol; 1993 Nov; 22(6):1723-9. PubMed ID: 8227846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slowing of ventricular tachycardia as a possible endpoint for serial drug testing at electrophysiological study.
    Handlin LR; Brodine WN; Gibbs H; Vacek JL
    Pacing Clin Electrophysiol; 1992 Jun; 15(6):864-9. PubMed ID: 1376898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the results of electrophysiologic testing after short-term and long-term treatment with amiodarone in patients with ventricular tachycardia.
    Rosenheck S; Sousa J; Calkins H; Schmaltz S; deBuitleir M; Kadish AH; Morady F
    Am Heart J; 1991 Jun; 121(6 Pt 1):1693-8. PubMed ID: 2035383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of electrophysiologic testing in the treatment of drug-refractory ventricular arrhythmias with amiodarone.
    Borggrefe M; Breithardt G
    Eur Heart J; 1986 Sep; 7(9):735-42. PubMed ID: 3769956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic testing in patients who respond acutely to intravenous amiodarone for incessant ventricular tachyarrhythmias.
    Kowey PR; Marinchak RA; Rials SJ; Rubin AM; Smith L
    Am Heart J; 1993 Jun; 125(6):1628-32. PubMed ID: 8498304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia.
    Man KC; Williamson BD; Niebauer M; Daoud E; Bakr O; Strickberger SA; Hummel JD; Kou W; Morady F
    Am J Cardiol; 1994 Dec; 74(11):1119-23. PubMed ID: 7977070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of the efficacy and safety of adjuvant metoprolol and xamoterol in combination with amiodarone for resistant ventricular tachycardia associated with impaired left ventricular function.
    Bashir Y; Paul VE; Griffith MJ; Sneddon JF; Farrell TG; Ward DE; Camm AJ
    Am Heart J; 1992 Nov; 124(5):1233-40. PubMed ID: 1442491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
    Veltri EP; Reid PR; Platia EV; Griffith LS
    Am J Cardiol; 1985 Feb; 55(4):375-9. PubMed ID: 3969872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictive factors of induction of ventricular arrhythmia under amiodarone].
    Bourret N; Kirkorian G; Chevalier P; Bellon C; Richalet C; Bouchayer D; Bonnefoy E; Touboul P
    Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1277-81. PubMed ID: 8952825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive and noninvasive methods to predict the long-term efficacy of amiodarone: a compilation of clinical observations using meta-analysis.
    Roberts SA; Viana MA; Nazari J; Bauman JL
    Pacing Clin Electrophysiol; 1994 Oct; 17(10):1590-602. PubMed ID: 7800560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of early electrophysiologic testing in determining long-term outcome with amiodarone treatment in patients with sustained ventricular tachycardia.
    Shannon JA; Hammill SC; Gersh BJ
    Mayo Clin Proc; 1991 Nov; 66(11):1114-9. PubMed ID: 1943242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment.
    Schmitt C; Brachmann J; Waldecker B; Rizos I; Senges J; Kübler W
    Am Heart J; 1987 Aug; 114(2):279-83. PubMed ID: 3604883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency-dependent electrophysiologic effects of amiodarone in humans.
    Sager PT; Uppal P; Follmer C; Antimisiaris M; Pruitt C; Singh BN
    Circulation; 1993 Sep; 88(3):1063-71. PubMed ID: 8353868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
    McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
    Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone is poorly effective for the acute termination of ventricular tachycardia.
    Marill KA; deSouza IS; Nishijima DK; Stair TO; Setnik GS; Ruskin JN
    Ann Emerg Med; 2006 Mar; 47(3):217-24. PubMed ID: 16492484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.